IRCT201106214856N2已完成2 期
Outcoms of intravitreal injection of bevacizumab in patients with acute Branch retinal Vein Occlusion(BRVO)
Vice chancellor for research, Baqiyatallah University of Medical Science0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 35 years 至 80 years（—）
- 性别
- All
入选标准
- •Inclusion: Patients with initial diagnose of branch retinal vein occlusion(BRVO) based on examination with Slit Lamp; Less than one week of symptoms onset.
- •Exclusion: Other pathologies of retinal vessels beside BRVO based on flurcein angiography(FA); Patients that have recevied any medication for BRVO.
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Effect of diclofenac eye drop and Bevacizumab and Triamcinolone in preventing part of the retina edemaDiabetic retinopathyDiabetic retinopathy.IRCT2017050833875N1Vice chancellor For Research Of Ahvaz Jundishapur University of Medical Sciences45
招募中
4 期
Efficacy of bevacizumab by intravitreal route in choroidal neovascular membrane of eye.CTRI/2016/09/007288Govt medical college and sir takhtsinhji hospital bhavnagr30
进行中（未招募）
不适用
Silmän sisäisten lääkeainepistosten aikaan saama hermoston uudelleen muokaantuvuusEUCTR2012-000765-20-FIKuopion yliopistollinen sairaala/silmätautien poliklinikka
已完成
不适用
Evaluate the effect of intravitreal Bevacizumab injection for ocular proliferative diseaseschoroidal neovascularization,proliferative diabetic retinopathy, central retinal vein occlusion neovascular glaucomaJPRN-UMIN000020467agasaki University Hospital90
尚未招募
不适用
The response of intravitreal bevacizumab in the treatment of intraocular neovascularizatioOcular neovascularizationJPRN-UMIN000009389Osaka University Hospital80